
CNBC’s Meg Tirrell sits down with Gilead CEO Daniel O’Day amid the American Society of Clinical Oncology conference in Chicago to discuss the company’s latest data surrounding its cancer drug Trodelvy.
CNBC’s Meg Tirrell sits down with Gilead CEO Daniel O’Day amid the American Society of Clinical Oncology conference in Chicago to discuss the company’s latest data surrounding its cancer drug Trodelvy.